Alt Text
Office of Neuroscience Research > WUSTL Neuroscience News > NIH Weekly Funding Opportunities, Notices: October 13, 2017

NIH Weekly Funding Opportunities, Notices: October 13, 2017



Notices
Requests for Applications
Program Announcements

     

  • Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp)
    (PA-18-314)
    National Cancer Institute
    National Center for Advancing Translational Sciences
    National Center for Emerging and Zoonotic Infectious Diseases 
    National Human Genome Research Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Institute for Occupational Safety and Health
    Application Receipt Date(s): December 18, 2017, by 5:00 PM local time of applicant organization. 

     

  • Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional)
    (PA-18-322)
    National Center for Complementary and Integrative Health
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)
    (PA-18-323)
    National Center for Complementary and Integrative Health
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Limited Competition: Brain Tissue Resource Center for Alcohol Research (R28)
    (PAR-17-305)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): December 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
    (PAR-17-306)
    Office of Disease Prevention
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute on Minority Health and Health Disparities 
    Application Receipt Date(s): New applications: February 5, 2018; October 5, 2018; June 5, 2019; February 5, 2020; October 5, 2020, by 5:00 PM local time of applicant organization. Resubmission applications: March 5, 2018; November 5, 2018; July 5, 2019; March 5, 2020; November 5, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)
    (PAR-18-307)
    Office of Disease Prevention
    Application Receipt Date(s): New applications: February 16, 2018; October 16, 2018; June 16, 2019; February 16, 2020; October 16, 2020, by 5:00 PM local time of applicant organization. Resubmission applications: March 16, 2018; November 16, 2018; July 16, 2019; March 16, 2020; November 16, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed
    (PAR-18-310)
    National Cancer Institute
    Application Receipt Date(s): February 14, 2018; July 10, 2018; October 8, 2018; February 13, 2019; July 10, 2019; October 8, 2019; February 13, 2020; July 10, 2020; October 8, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)
    (PAR-18-313)
    National Cancer Institute
    National Institute of Dental and Craniofacial Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)
    (PAR-18-317)
    National Cancer Institute
    Application Receipt Date(s): February 14, 2018; July 10, 2018; October 8, 2018; February 13, 2019; July 10, 2019; October 8, 2019; February 13, 2020; July 10, 2020; October 8, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
    (PAR-18-319)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): March 13, 2018; March 13, 2019; March 13, 2020 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.